Paul Howard and former FDA Commissioner, Dr. Andrew C. von Eschenbach, discuss the FDA's recent decision revoking Avastin's approval for the treatment of metastatic breast cancer
Paul Howard and former FDA Commissioner, Dr. Andrew C. von Eschenbach, discuss the FDA's recent decision revoking Avastin's approval for the treatment of metastatic breast cancer.